Dive Brief: AllRock Bio, a biotechnology startup founded by a team of former CinCor...

Dive Brief: Just weeks after announcing a major restructuring, Australian drugmaker CSL struck a...

A federal vaccine panel will meet this week for the second time since it...

Dive Brief: An experimental drug from biotechnology company aTyr Pharma missed its main goal...

Dive Brief: Novo Nordisk on Wednesday announced plans to lay off about 11% of...

Today, a brief rundown of news involving Kriya Therapeutics and Odyssey Therapeutics, as well...

Dive Brief: The Food and Drug Administration on Wednesday issued draft recommendations for drugmakers...

Dive Brief: Capsida Biotherapeutics has suspended a recently begun clinical trial of an experimental...

What could GLP-1 drugs, known for their powerful weight loss benefits, have to do...

Today, a brief rundown of news involving Takeda Pharmaceutical and Maze Therapeutics, as well...

Senior Food and Drug Administration official Vinay Prasad has reclaimed a role as the...

Dive Brief: The Food and Drug Administration on Tuesday approved a drug-device combination for...

LB Pharmaceuticals raised $285 million in an initial public offering on Wednesday, marking the...

This compelling four-part podcast series, “The Progress Profile: Alzheimer’s Research in Focus,” brings together...

Eli Lilly will give small biotechnology companies a chance to use artificial intelligence models...

Drug developers from around the world rang in a new era of sleep medicine...

Dive Brief: BioNTech’s experimental bispecific cancer drug pumitamig helped shrink tumors in three-quarters of...

Artificial intelligence (AI) has quietly become a part of our daily lives – through...

Dive Brief: Enveda Biosciences said Thursday it raised $150 million in Series D financing,...

Dive Brief: Sanofi shares dropped after the French drugmaker reported results from a highly...

Dive Brief: The Food and Drug Administration plans to work more closely and flexibly...

A newly launched startup is the latest young company to build itself around a...

Today, a brief rundown of news involving the Food and Drug Administration and Gilead...

Prolific biotechnology investment firm Atlas Venture said Thursday it raised $400 million to pump...

U.S. lawmakers clashed with Health and Human Services Secretary Robert F. Kennedy Jr. over...

For the past four years or so, veteran drug hunters Josh Bilenker and Jeff...

Biohaven’s top executive said his team is well-prepared to sell a therapy that could...

Novartis is once again taking aim at Parkinson’s disease, through a deal with Arrowhead...

Today, we’re catching up after a long weekend on news involving Amgen and Replimune,...

The biotechnology careers of John Maraganore and Clive Meanwell have brought them into collaboration...

The case of Stealth BioTherapeutics and its rare disease drug could become a regulatory...

Dive Brief: Wugen said Wednesday that it brought in $115 million in a new...

Today, a brief rundown of news involving Amylyx Pharmaceuticals and Sanofi, as well as...

Dive Brief: Novo Nordisk is again looking for help outside its own laboratories as...

A federal vaccine panel recently remade by Health and Human Services Secretary Robert F....

Dive Brief: People with early breast cancer who were treated in a late-stage study...

The Food and Drug Administration on Wednesday approved updated COVID-19 vaccines that target a...

Dive Brief: An RNA medicine developed by Regeneron Pharmaceuticals and Alnylam Pharmaceuticals helped control...

Dive Brief: Eli Lilly on Tuesday said it is ready to ask the Food...

The Food and Drug Administration has suspended the license of Valneva’s chikungunya vaccine following...

Dive Brief: Royalty Pharma has grabbed rights to a share in revenue from lung...

A much-anticipated report from the Make America Healthy Again Commission was postponed earlier this...

Dive Brief: Rocket Pharmaceuticals plans to restart a Phase 2 gene therapy trial for...

The United States and the European Union formalized the terms of the framework trade...

Dive Brief: Sarepta on Thursday said it’s reached agreements that remove about $700 million...

Today, a brief rundown of news involving Biohaven and Catalent, as well as updates...

Dive Brief: Gilead Sciences is deepening its investment in cancer cell therapy, announcing Thursday...

The Food and Drug Administration on Thursday approved a drug Ionis Pharmaceuticals developed for...

Eli Lilly is searching for a new neuroscience chief after announcing Wednesday that the...

Xoma Royalty Corp. is acquiring another struggling biotechnology company in further sign of interest...

Dive Brief: Australian drugmaker CSL is separating its vaccine business, Seqirus, into a standalone...

Dive Brief: An experimental weight loss pill from Viking Therapeutics helped people with obesity...

Otello Stampacchia has watched the biotechnology industry survive many dark days in the two...

Dive Brief: Stealth BioTherapeutics is once again seeking U.S. approval of a drug for...

Over the next five years, several blockbuster oncology drugs from leading pharmaceutical companies will...

The Trump administration recently added to an ongoing push to boost pharmaceutical manufacturing in...

Vedanta Biosciences, a startup working on microbiome drug research for more than a decade,...

Merck KGaA has been making moves to propel itself into becoming what CEO Belén...

Today, a brief rundown of news involving Precigen and Pfizer, as well as updates...

The Department of Health and Human Services announced Thursday it will reinstate a disbanded...

Dive Brief: Sarepta on Wednesday announced the divestment of its entire equity stake in...

Eli Lilly on Thursday responded to a Trump administration plan to lower U.S. drug...

Dive Brief: Vor Biopharma on Wednesday said a late-stage study run in China by...

AbbVie plans to spend $195 million to build a new facility to produce active...

Dive Brief: PureTech Health, a biotechnology firm with a web of startup subsidiaries, announced...

Dive Brief: Insmed has gained approval for its second lung disease medicine, announcing Tuesday...

An experimental cancer vaccine fell short of its main objective in a Phase 3...

Strand Therapeutics has raised a $153 million Series B round fresh off unveiling early,...

Iovance Biotherapeutics will lay off staff in a restructuring that follows a significant cut...

The Department of Health and Human Services is canceling nearly $500 million in contracts...

Pfizer and other large pharmaceutical companies are taking seriously President Donald Trump’s demand that...

Lawmakers in Washington share U.S. drugmakers’ angst about being surpassed by China’s fast-progressing biotechnology...

Dive Brief: David Altshuler, the renowned geneticist who’s helped shape Vertex Pharmaceuticals’ research strategy...

The Gates Foundation on Monday said it is committing to invest $2.5 billion over...

Viral-based gene therapies (GTs) represent a new frontier in medicine, offering hope to patients...

Frazier Life Sciences on Thursday said it has closed a new venture capital fund...

Dive Brief: Sales of an Alnylam Pharmaceuticals rare disease medicine substantially outpaced Wall Street...

Biotechnology companies specializing in psychedelics research saw their share prices rise after rumors of...

The 17 vaccine advisers fired by Robert F. Kennedy Jr. last month called Wednesday...

Today, a brief rundown of news involving Regeneron Pharmaceuticals and Allogene Therapeutics, as well...

The U.S. plans to lift its pause on country-specific tariffs while implementing a range...

President Donald Trump on Thursday threatened 17 large drugmakers with “every tool in [the...

Vinay Prasad’s sudden resignation from the Food and Drug Administration Tuesday once again leaves...

Today, a brief rundown of news involving Madrigal Pharmaceuticals and Viridian Therapeutics, as well...

Vinay Prasad, the controversial head of the Food and Drug Administration office that oversees...

Dive Brief: Merck & Co. is launching a new cost-cutting program, announcing Tuesday a...

Vaccine maker Bavarian Nordic on Monday said it has agreed in principle to a...

The Food and Drug Administration has given Sarepta Therapeutics a green light to resume...

The small, brain-focused biotechnology company Atai Life Sciences plans to direct resources away from...

Today, a brief rundown of news involving Rocket Pharmaceuticals and Atara Biotherapeutics, as well...

Dive Brief: Galapagos on Wednesday said it’s considering selling its cell therapy business, which...

A key committee that helps decide what new medicines enter the European market has...

AstraZeneca executive Cristian Massacesi will join Bristol Myers Squibb as its chief medical officer,...

The Food and Drug Administration has delayed its review of a Bayer therapy for...

European drug regulators on Friday recommended rejecting Sarepta Therapeutics’ Elevidys in the latest setback...

TCG Labs Soleil, a venture firm building narrowly focused biotechnology startups and readying them...

An experimental drug from AstraZeneca succeeded in a late-stage trial in an autoimmune condition...

Health and Human Services Secretary Robert F. Kennedy Jr. on Wednesday endorsed a federal...

Dive Brief: A new biotechnology company debuted Wednesday with a hefty bankroll and an...

Dive Brief: French pharmaceutical giant Sanofi said Tuesday it will pay $1.15 billion to...

Sarepta Therapeutics said Monday evening it will temporarily pause all shipments of its Elevidys...

WASHINGTON — AstraZeneca, the U.K.’s third biggest company by market value, is making itself...

The AAV-based therapeutic market continues to evolve rapidly. The past few years have seen...

Bristol Myers Squibb and Pfizer will begin offering their top-selling heart medicine Eliquis through...

Another person treated with a Sarepta Therapeutics gene therapy has died, compounding concerns about...

Today, a brief rundown of news involving Bristol Myers Squibb and the Food and...

A panel of medical experts called for the removal of warning labels on hormone...

The Food and Drug Administration will ask Sarepta Therapeutics to halt all shipments of...

Novartis is exploring options to meet the Trump administration’s goal of bringing U.S. drug...

Dive Brief: New data from HSBC Innovation Banking add further evidence venture capital funding...

An experimental rare disease drug from AstraZeneca failed in two late-stage trials, though the...

Sarepta Therapeutics is laying off roughly 500 employees in an extensive workforce reduction that...

Dive Brief: An experimental, dual-acting obesity drug from Hengrui Pharma and biotechnology startup Kailera...

Dive Brief: LaNova Medicines, a cancer drugmaker that previously licensed medicines to Merck &...

A group of private equity firms are pouring funding into PCI Pharma Services, betting...

Dive Brief: An experimental drug being developed by AstraZeneca significantly reduced blood pressure versus...

In a race where every day counts, speed has become a defining metric for...

Dive Brief: AbbVie agreed to pay Ichnos Glenmark $700 million upfront for rights to...

The Food and Drug Administration on Thursday published more than 200 drug rejection letters...

The Food and Drug Administration has rejected what was set to be the first...

Merck & Co.’s $10 billion acquisition of Verona Pharma Wednesday is a dramatic outcome...

Today, a brief rundown of news involving Valneva and Jazz Pharmaceuticals, as well as...

Dive Brief: The Food and Drug Administration on Thursday granted full approval for Moderna’s...

The first marketed treatment for the insatiable hunger associated with Prader-Willi disease is selling...

The drug industry’s efforts to develop a treatment for a rare kidney condition known...

Dive Brief: The Food and Drug Administration has approved a modified dosing schedule for...

Dive Brief: Actithera, a radiopharmaceutical drugmaker based in Oslo, Norway and Cambridge, Massachusetts, has...

President Donald Trump is planning to introduce tariffs of 50% on copper imports and...

For decades now, scientists have been experimenting with a new way to target and...

Six medical groups and a pregnant physician have sued Health and Human Services Secretary...

Dive Brief: Abbvie has agreed to acquire cell therapy developer Capstan Therapeutics in a...

Acadia Pharmaceuticals, the brain-focused drug developer, surprised some on Wall Street last week with...

Dive Brief: Organon’s experimental treatment for endometriosis failed to improve pelvic pain for women...

Today, a brief rundown of news involving Regeneron Pharmaceuticals, IGM Biosciences and Catalio Capital,...

In the notoriously expensive business of drug development, SiteOne Therapeutics made do with little....

Dive Brief: Atai Life Sciences and Beckley Psytech are making plans to push the...

Dive Brief: Moderna’s seasonal influenza vaccine met its main goal in a large Phase...

Dive Brief: Sage Therapeutics will lay off 338 employees, the vast majority of its...

Dive Brief: Incyte has named veteran pharmaceutical executive Bill Meury as its new CEO,...

Acadia Pharmaceuticals has proposed that its pipeline of experimental medicines could, if eventually brought...

Bipartisan policies in Congress meant to lower drug costs by targeting middlemen in the...

The Supreme Court on Friday upheld a popular provision of the Affordable Care Act that...

Today, a brief rundown of news involving Biocryst and Peter Marks, as well as...

Dive Brief: The Food and Drug Administration is easing limitations it imposed around the complex...

Dive Brief: Vor Biopharma is licensing rights to an immune disease drug from Chinese...

Dive Brief: Advisers to the Centers for Disease Control and Prevention recommended Thursday that...

Dive Brief: Kymera Therapeutics and Gilead Sciences will develop oral molecular glue degraders under...

Robert F. Kennedy Jr.’s newly hand-picked panel of federal vaccine advisers met for the...

Dive Brief: Perceptive Xontogeny Venture Funds and venBio Partners are contributing up to $40...

Today, a brief rundown of news involving Sarepta Therapeutics, Capricor Therapeutics and Nektar Therapeutics,...

Dive Brief: A top Food and Drug Administration official responsible for overseeing drug reviews...

On the heels of the BIO International Convention and as I reflect on the...

In the last episode of the podcast Balancing the Future, hosted by Chai Nussbaumer...

Today, a brief rundown of news involving CSL and Intellia Therapeutics, as well as...

Dive Brief: Two senior officials at the Food and Drug Administration office that regulates...

Biotechnology industry watchers were hopeful at the start of 2025. Venture funding appeared to...

Today, a brief rundown of news involving Prothena and Zealand Pharma, as well as...

Dive Brief: Actio Biosciences, a San Diego-based biotechnology startup, announced Wednesday it raised a...

Psychiatric medicine remains one of the more challenging and risky areas of drug research....

Dive Brief: A medicine developed to treat a genetic muscle-wasting disease can improve results...

The Food and Drug Administration has approved a new way to prevent HIV, clearing...

Food and Drug Administration Commissioner Martin Makary has proposed a dramatic expansion of the...

Dive Brief: Eli Lilly agreed to buy Verve Therapeutics for $1 billion, betting on...

Dive Brief: Roche will advance an experimental Parkinson’s disease drug with a mixed track...

When the deadline to appeal the court decision that blocked the Food and Drug...

Dive Brief: The Food and Drug Administration has approved a new oral medication for...

Today, a brief rundown of news involving Insmed and Recursion Pharmaceuticals, as well as...

The budget bill currently under consideration in Congress is big — and it’s complicated....

Listen to the article 4 min This audio is auto-generated. Please let us know...

The Food and Drug Administration has approved wider use of Moderna’s respiratory syncytial virus...

Dive Brief: Novo Nordisk is planning Phase 3 clinical trials for a obesity drug...

Health and Human Services Secretary Robert F. Kennedy Jr. on Wednesday continued his efforts...

Dive Brief: COVID vaccine maker BioNTech is buying rival CureVac, announcing Thursday an all-stock deal...

Dive Brief: Bristol Myers agreed to pay $350 million up front to Philochem for...

SpliceBio, a Spanish biotechnology company working on next-generation gene therapies, said Wednesday it raised...

Dive Brief: Health and Human Services secretary Robert F. Kennedy Jr., has abruptly fired...

Fresh off a multibillion-dollar deal with Eli Lilly, cancer drug startup Scorpion Therapeutics is...

Elevation Oncology has agreed to be acquired by an investment firm focused on buying...

The Food and Drug Administration has cleared a new treatment designed to protect infants...

Sometimes, the right advances in medicine catch the public’s imagination—opening a world of possibilities...

Dive Brief: Looking to defend its giant cardiometabolic health franchise, Eli Lilly is licensing...

The amount of funding going into biotechnology companies has fallen off over the last...

The Food and Drug Administration aims to roll out its new AI tool, called...

Today, a brief rundown of news involving Otsuka Pharmaceutical and Arvinas, as well as...

Anyone looking for evidence of genetic medicine’s enormous promise need only read of KJ...

New drugs, however heralded, take time to embed into clinical care. Enhertu, the powerful...

Dive Brief: After changing its name and focus, Cullinan Therapeutics is beefing up its...

CHICAGO — Hiroyuki Okuzawa holds an enviable position. The veteran Daiichi Sankyo executive took...

Dive Brief: The Food and Drug Administration has awarded Sarepta Therapeutics a new kind...

CHICAGO — A Johnson & Johnson drug currently used for advanced prostate cancer can help...

An experimental, non-hormonal drug from Bayer can reduce the hot flashes and other menopausal...

CHICAGO — The American Society of Clinical Oncology’s annual meeting is a forum for...

Dive Brief: An experimental protein-degrading drug from Kymera Therapeutics appeared safe and able to...

What we commonly refer to as “lung cancer” is in fact many different types...

CHICAGO — Funding cancer research isn’t usually a political flashpoint. But as the Trump...

AstraZeneca and Daiichi Sankyo’s targeted cancer medicine Enhertu helped participants in a late-stage clinical...

The Food and Drug Administration has granted an approval to Moderna’s next-generation COVID-19 vaccine,...

Today, a brief rundown of news involving Astellas Pharma and Keros Therapeutics, as well...

Dive Brief: A dual-acting drug developed by Summit Therapeutics and Akeso delayed tumor progression...

Dive Brief: Intellia Therapeutics shares dropped 25% early Thursday after the gene-editing company disclosed...